Coagulation and complement protein differences between septic and uninfected systemic inflammatory response syndrome patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 62, Issue 5, 2007, Pages 1082-1092

  Lissauer, Matthew E ^a,d   Johnson, Steven B ^a   Siuzdak, Gary ^b   Bochicchio, Grant ^a   Whiteford, Craig ^c   Nussbaumer, Bill ^c   Moore, Richard ^c   Scalea, Thomas M ^a  

^a R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

^b Mass Consortium Corporation   (United States)

^c BD Diagnostics   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; COMPLEMENT; PLASMA PROTEIN; TRYPSIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; COMPLEMENT SYSTEM; COMPUTER PROGRAM; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYMATIC DEGRADATION; FEMALE; HUMAN; INFECTION; INTENSIVE CARE UNIT; ION TRAP MASS SPECTROMETRY; LECTIN BINDING; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; SEPSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; COMPLEMENT SYSTEM PROTEINS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMA SEVERITY INDICES;

EID: 34248396829     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31804d23e1     Document Type: Article

References (31)

1. Sprung CL, Sakr Y, Vincent J-L, et al. An evaluation of systemic inflammatory response syndrome signs in the sepsis occurrence in acutely ill patients (SOAP) study. Intensive Care Med. 2006;32: 421-427.
2. Rivers E, Nguyen B, Havsted S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368-1377.
3. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858-873.
4. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113:227-242.
5. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory syndrome and sepsis in the critically ill patient? Intensive Care Med. 2002; 28:1351-1356.
6. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med. 2006;34:1996-2003.
7. Tolson J, Bogumil R, Brunst E, et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest. 2004;84:845-856.
8. Paweletza CP, Trock B, Pennanene M, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: Potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers. 2001;17:301-307.
9. Zhang Z, Bast Jr RC, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004;64:5882-5890.
10. Buhimschi IA, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG. 2005;112:173-181.
11. American College of Chest Physician/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
12. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med. 1992;20:724-726.
13. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-1256.
14. Shen Z, Want EJ, Chen W, et al. Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. J Proteome Res. 2006;10:1021.
15. Wei J, Sun J, Jones A, et al. Global proteome discovery using an online three-dimensional LC-MS/MS. J Proteome Res. 2005;4:801-808.
16. Dennis G Jr., Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3.
17. Hosack DA, Dennis G, Sherman BT, et al. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:P4.
18. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27-30.
19. Kanehisa M, Goto S, Hattori M, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006; 34:D354-357.
20. Biocarta Pathways. Available at http://www.biocarta.com/genes/index.asp. Accessed August 30, 2006.
21. Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: a non-redundant list developed by a combination of four separate sources. Mol Cell Proteomics. 2004;3:311-326.
22. Lissauer M, Johnson SB, Bochicchio G, et al. Toll like receptor pathway gene expression: Sepsis or uninfected systemic inflammatory response syndrome? Crit Care Med. 2005;33:A163.
23. Bhole D, Stahl GL. Therapeutic potential of targeting the complement cascade in critical care medicine. Crit Care Med. 2003; 31:S97-S104.
24. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
25. Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care. 2004;8:R82-R90.
26. Utter GH, Owings JT, Jacoby RC, Gosselin RC, Paglieroni TG. Injury induces increased monocyte expression of tissue factor: Factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J Trauma. 2002;52:1071-1077.
27. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989; 134:1087-1097.
28. Volk T, Kox WJ. Endothelium function in sepsis. Inflamm Res. 2000;49:185-198.
29. Fan J, Yuehua L, Vodovotz Y, Billiar TR, Wilson MA. Hemorrhagic shock-activated neutrophils augment TLR4 signaling induced TLR2 upregulation in alveolar macrophages: Role in hemorrhage primed lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2006; 290:738-746.
30. Barsness KA, Arcaroli J, Harken AH, et al. Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol. 2004;287:R592-R599.
31. Tsung A, Hoffman RA, Izuishi K, et al. Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells. J Immunol. 2005;175:7661-7668.